Atlas Trials

LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study

Clinical trial NCT05957978 · COMPLETED

Trial details

NCT number
NCT05957978
Sponsor
Drugs for Neglected Diseases
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Visceral Leishmaniasis
Start date
2024-03-29
Primary completion
2025-06-27
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.